Entrada Therapeutics, Inc.TRDANASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
-0.43%
↑ 92% above average
Average (22q)
-5.59%
Historical baseline
Range
High:330.44%
Low:-271.40%
Volatility
-10764.0%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -0.43% |
| Q2 2025 | -115.00% |
| Q1 2025 | -271.40% |
| Q4 2024 | 72.91% |
| Q3 2024 | -140.54% |
| Q2 2024 | 153.03% |
| Q1 2024 | 330.44% |
| Q4 2023 | -64.99% |
| Q3 2023 | 185.97% |
| Q2 2023 | -181.99% |
| Q1 2023 | 77.40% |
| Q4 2022 | 1.38% |
| Q3 2022 | -9.98% |
| Q2 2022 | -6.46% |
| Q1 2022 | -19.99% |
| Q4 2021 | -28.52% |
| Q3 2021 | -44.94% |
| Q2 2021 | -18.07% |
| Q1 2021 | 3.00% |
| Q4 2020 | -24.09% |
| Q3 2020 | -26.31% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |